Abstract
Background
Depression substantially impacts on quality of life, personal relationships, and self-care. Gastrointestinal disorders are the common comorbidity of depression and 24.3% of patients with depression have disordered bowel habits. Dietary intake of live microbes alters the host’s microflora and is beneficial for the prevention and control of bowel health and depression. We aim to investigate the association of dietary intake of live microbes with bowel health and depression and to further examine weather bowel health or depression mediates the therapeutic effect of live microbes.
Methods
Participants’ data were obtained from the National Health and Nutrition Examination Survey (NHANES) 2005–2010, which is designed to examine the health and nutritional status of the non-institutionalized US population by a complex, multi-stage, probability sampling design. The foods were grouped into categories on the basis of estimated microbial levels: low (<104 CFUs/g), medium (Med; 104–107 CFU/g), and high (Hi; >107 CFU/g). Participants were further classified into three groups (G1: participants without MedHi foods intakes; G2: those with MedHi foods intakes greater than zero but less than the median; and G3: those with MedHi foods intakes greater than the median).
Results
A total of 10,785 US adults were selected. The median of MedHi foods intake was 66.1 g/day. Participants in the G2 (OR = 0.739, 95% CI: 0.581–0.941) and G3 (OR = 0.716, 95% CI: 0.585–0.877) groups had significant association with lower risks of depression, and participants in the G3 group had significant association with lower risks of hard stools (OR = 0.885, 95% CI: 0.692–0.989) and loose stools (OR = 0.769, 95% CI: 0.585–0.954). Interestingly, further mediation analyses showed that the association of dietary live microbe intake with depression is mediated by the stool types, and the association of dietary live microbe intake with stool types is mediated by the depression (all P < 0.05).
Conclusions
A high dietary intake of live microbes, especially a minimum of 66.1 g of MedHi foods per day, is associated with a lower risk of depression, hard stools, and loose stools consistency. Depression and bowel health mutually act as mediators in this association, indicating dietary intake of live microbes may simultaneously affect bowel health and depression.
Keywords: Dietary live microbe, Bowel health, Depression, NHANES
Graphical Abstract
1. Introduction
Depression is a common mental disorder in the United States (US), with an estimated 7.8% (19.4 million) of US adults experienced at least 1 major depressive episode in 2019 [1]. Depression substantially impacts on quality of life, personal relationships, and self-care, thereby enhancing mortality, higher risk of cardiovascular events, and exacerbating of comorbid conditions [2–4]. Major depressive disorder (MDD) is a severe form of depression, with the incremental economic burden of populations with MDD increased by 37.9% from $236.6 billion to $326.2 billion between 2010 and 2018 [5].
Gastrointestinal disorders are the common comorbidity of depression [6, 7]: 24.3% of patients with depression have disordered bowel habits, 16% ones have chronic diarrhea, and 9% ones have chronic constipation [8]. Moreover, gastrointestinal side effects, associated with antidepressant treatments, such as nausea, abdominal pain, diarrhea, and constipation, are frequently observed in patients with MDD. These side effects may lead to treatment discontinuation [9]. Similarly, 15% of patients with inflammatory bowel disease (IBD) develop depression [10]. Depression may cause intestinal disturbances through the brain-gut-microbiome axis (BGMA), which constitutes a bidirectional communication system comprising neural, endocrine/metabolic, immunological and microbial signals, and vice versa [11, 12].
Dietary intake of live microbes alters the host’s microflora and is beneficial for the prevention and control of gastrointestinal diseases [13, 14], cardiovascular diseases [15–17], periodontitis [18], and depression [19, 20]. Treatment with probiotics ameliorates the intensity of depression in patients with MDD [21]. Meanwhile, probiotics is effective for acute infectious diarrhea [22], antibiotic-associated diarrhea [23] and constipation [24, 25].
Although the effect of live microbes on the treatment of depression or gastrointestinal disorders is well established, it is still unclear how dietary intake of live microbes associates with comorbidity of depression and gastrointestinal disorders. In this study, we investigated the association of the dietary intake of live microbes with the risk of depression or gastrointestinal disorders, further examining whether depression or bowel health mutually mediates the therapeutic effect of live microbes using the data from National Health and Nutrition Examination Survey (NHANES).
2. Materials and methods
2.1. Study population
NHANES is a large, ongoing, nationally representative, cross-sectional survey of the noninstitutionalized civilian population designed to monitor the nutritional, dietary, and health status of Americans. This study was approved by the National Center for Health Statistics (NCHS) and Research’s Ethics Review Committee, and each participant signed an informed consent form. Detailed descriptions of the subject recruitment, survey design, and data collection procedures are available online [26]. Participants aged 20 years and above from 2005–2010 cycles of NHANES were included in this study only if they completed the Bowel Health Questionnaire. Additionally, we excluded participants with self-reported history of inflammatory bowel disease, celiac disease, colon cancer, pregnancy and/or breastfeeding, unavailable information on live microbes or depression, and any missing data.
2.2. Dietary intake of live microbes
Dietary intakes were estimated using data from 24-h dietary recall collected through in-person interviews. The estimated quantities of live microbes (CFU/g) for 9388 food codes contained in 48 subgroups in the NHANES database were determined by 4 experts [27]. The foods were categorized on the basis of estimated microbial levels: low (<104 CFUs/g), medium (Med, 104–107 CFU/g), and high (Hi, >107 CFU/g). Given that the simultaneous inclusion of both Med and Hi food categories in one model indicated that their coefficients were comparable, we utilized a new category, termed ‘MedHi’, in line with the methodology of previous studies [16, 27]. MedHi referred to foods that were categorized as either having medium or high microbial content. We then calculated the grams of the new categories of food consumed for each participant, and the participants who were finally enrolled were further classified into three groups (G1: participants without MedHi foods intakes; G2: those with MedHi foods intakes greater than zero but less than the median; and G3: those with MedHi foods intakes greater than the median).
2.3. Bowel Health Questionnaire and Depression Questionnaires
The bowel health questionnaires from the NHANES 2005–2010 were used to analyze bowel symptoms in participants with self-reported bowel habits. Participants were shown a card with colored pictures and descriptions of the seven Bristol Stool Form Scale types (BSFS; Type 1–Type 7) and asked to ‘Please look at this card and tell me the number that corresponds with your usual or most common stool type (stool consistency)’. Stool consistency was categorized into hard stools (types 1 and 2), normal stools (types 3 and 4), and loose stools (types 5, 6 and 7) [28].
Depression Screener from the 2005–2010 NHANES was used to identify individuals with depression. This screener consisted of the Patient Health Questionnaire 9 (PHQ-9) [29]. The PHQ-9 had information about symptoms of depression on a 4 point scale (“0” = not at all; “3” = nearly every day) over the past 2 weeks with scores ranging from 0–27. A cutoff value of 10 was used to define individuals with depressive symptoms according to a previous study [30]: individuals with scores of 9 or below were classified as not exhibiting clinically significant depressive symptoms, whereas those with scores of 10 or higher were identified as having depressive symptoms of clinical relevance.
2.4. Covariates
General characteristics of participants included sex (male or female), race and ethnicity (Hispanic, non-Hispanic White, non-Hispanic Black, and other race), marital status (married, unmarried/cohabitation, and divorced/widowed/separated), smoking (never, former, and now), and drinking (never, former, mild [an average intake of no more than 1 drink per day for women and 2 drinks per day for men], moderate [an average intake of no more than 3 drinks per day for women and 4 drinks per day for men], and heavy [an average of 4 or more drinks per day for women and 5 or more drinks per day for men]). Body mass index (BMI) was defined as weight in kilograms divided by the square of height in meters (kg/m2). Body weight status in this study was classified as follows: healthy weight and underweight (BMI < 25 kg/m2), overweight (25.0–29.9 kg/m2), and obesity (BMI ≥ 30.0 kg/m2). Physical activity (PA) was assessed using the data of self-reported Global Physical activity Questionnaire (GPAQ) [31]. According to the physical activity guideline from the American College of Sports Medicine (ACSM), active PA was defined as 150 min of moderate PA or 75 min of vigorous PA. Except active PA, others were defined as inactive PA [32, 33].
2.5. Statistical analysis
Statistical analyses were performed under the complex sampling weight of NHANES according to the CDC guidelines [34]. For weighted characteristics description, continuous variables were analyzed using the survey-weighted linear regression, and categorical variables were analyzed using the survey-weighted Chi-square test. The continuous variables were presented as mean ± standard error (SE) and categorical variables were presented as percentages. Generalized linear model (GLM) was performed to analyze odds ratios (OR) and 95% confidence interval (CI) for the association of dietary intake of live microbes with depression and stool types, as well as the association of stool types with depression on the basis of Model 1 (age and sex were adjusted), and Model 2 (sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate were adjusted). The GLM framework provided a flexible approach to model a wide range of data types by combining the linear model’s principles with a variety of probability distributions and link functions, functioning as a versatile tool in statistical analysis. All analyses were performed using the statistical software packages R (The R Foundation; version 4.2.1) and EmpowerStats (www.empowerstats.net, X&Y solutions, Inc., Boston, Massachusetts), and P-values < 0.05 was considered statistically significant.
3. Results
3.1. General characteristics of participants
A total of 10,785 participants were finally enrolled in this study, the mean age of the participants was 50.2 years. In these participants, we found status-relevant stool (8,342 participants with normal stools, 784 participants with hard stools, and 1,659 participants with loose stools) and depressive status (907 participants with depression, and 9,878 participants without depression). Moreover, the median of MedHi of total participants was 66.1 gram/day (g/d): for amount of MedHi foods consumption, participants with intakes of MedHi foods (G1: 0.0 g/d, G2: 28.4 g/d, and G3: 183.4 g/d); for depression, those with depression (28.4 g/d), and those without depression (69.9 g/d); for stool types, those with normal stools (70.3 g/d), those with hard stools (51.3 g/d), and those with loose stools (53.0 g/d). The more detailed information about general characteristics of participants are showed in Table 1.
Table 1.
General characteristics of participants, NHANES 2005–2010 (Mean ± SE/N (weighted%))
| Characteristics | Total | Amount of MedHi foods consumption | Stool types | Depression | |||||
|
|
|
|
|||||||
| G1 | G2 | G3 | Normal | Hard | Loose | No | Yes | ||
| Overall | 10785 | 3508 (32.5) | 1856 (17.2) | 5421 (50.3) | 8342 (77.3) | 784 (7.3) | 1659 (15.4) | 9878 (91.6) | 907 (8.4) |
| MedHi (median: g/day) | 66.1 | 0.0 | 28.4 | 183.4 | 70.3 | 51.3 | 53.0 | 69.6 | 28.4 |
| Age | 50.2 ± 17.6 (47.4) | 48.8 ± 17.6 (45.6) | 48.9 ± 17.7 (46.2) | 51.5 ± 17.3 (48.8) | 50.2 ± 17.6 (47.3) | 48.5 ± 18.2 (46.2) | 51.2 ± 16.7 (48.5) | 50.5 ± 17.8 (47.5) | 47.5 ± 15.0 (45.8) |
| Sex | |||||||||
| Female | 5392 (51.2) | 1655 (48.0) | 947 (53.0) | 2790 (52.5) | 3932 (48.7) | 547 (73.6) | 913 (54.8) | 4820 (50.3) | 572 (62.9) |
| Male | 5393 (48.8) | 1853 (52.0) | 909 (47.0) | 2631 (47.5) | 4410 (51.3) | 237 (26.4) | 746 (45.2) | 5058 (49.7) | 335 (37.1) |
| Race/ethnicity | |||||||||
| Hispanic group | 2677 (11.2) | 809 (11.7) | 492 (11.8) | 1376 (10.7) | 1972 (10.5) | 216 (13.5) | 489 (14.2) | 2422 (11.0) | 255 (14.6) |
| Non-Hispanic White | 5667 (73.9) | 1618 (67.3) | 985 (74.1) | 3064 (77.6) | 4524 (75.3) | 361 (67.6) | 782 (69.1) | 5247 (74.6) | 420 (65.3) |
| Non-Hispanic Black | 2038 (9.9) | 939 (15.4) | 315 (9.4) | 784 (7.0) | 1538 (9.4) | 184 (14.3) | 316 (10.8) | 1843 (9.5) | 195 (15.1) |
| Other Race | 403 (4.9) | 142 (5.6) | 64 (4.6) | 197 (4.7) | 308 (4.8) | 23 (4.6) | 72 (5.9) | 366 (4.9) | 37 (5.0) |
| BMI | |||||||||
| <25 | 3015 (30.7) | 964 (29.4) | 506 (30.4) | 1545 (31.4) | 2368 (30.9) | 278 (38.5) | 369 (25.5) | 2796 (31.0) | 219 (26.5) |
| 25–29.9 | 3706 (33.7) | 1141 (31.5) | 647 (34.4) | 1918 (34.7) | 2929 (34.6) | 255 (33.1) | 522 (29.0) | 3449 (34.1) | 257 (28.5) |
| ≥30 | 4064 (35.6) | 1403 (39.1) | 703 (35.1) | 1958 (33.8) | 3045 (34.5) | 251 (28.4) | 768 (45.5) | 3633 (34.9) | 431 (45.1) |
| Marital status | |||||||||
| Married | 5915 (59.2) | 1758 (54.8) | 1004 (57.8) | 3153 (62.2) | 4607 (59.4) | 383 (53.6) | 925 (61.1) | 5565 (60.6) | 350 (41.2) |
| Unmarried/cohabitation | 2462 (22.9) | 894 (25.5) | 460 (24.7) | 1108 (20.8) | 1914 (23.2) | 202 (24.8) | 346 (20.3) | 2202 (22.5) | 260 (27.9) |
| Divorced/widowed/separated | 2408 (17.9) | 856 (19.6) | 392 (17.5) | 1160 (17.1) | 1821 (17.5) | 199 (21.6) | 388 (18.6) | 2111 (17.0) | 297 (30.9) |
| Smoking | |||||||||
| Never | 5620 (52.9) | 1710 (49.1) | 960 (52.3) | 2950 (55.1) | 4343 (53.1) | 467 (59.8) | 810 (48.1) | 5258 (53.9) | 362 (38.8) |
| Former | 2848 (25.8) | 827 (22.6) | 469 (23.3) | 1552 (28.4) | 2229 (26.0) | 163 (20.0) | 456 (27.2) | 2658 (26.2) | 190 (20.2) |
| Now | 2317 (21.4) | 971 (28.2) | 427 (24.3) | 919 (16.5) | 1770 (20.9) | 154 (20.2) | 393 (24.7) | 1962 (19.9) | 355 (41.0) |
| Drinking | |||||||||
| Never | 1359 (10.3) | 471 (11.3) | 241 (10.7) | 647 (9.6) | 976 (9.7) | 139 (15.0) | 244 (11.5) | 1254 (10.3) | 105 (9.9) |
| Former | 2159 (16.6) | 825 (20.1) | 367 (16.8) | 967 (14.5) | 1627 (15.8) | 172 (18.6) | 360 (20.1) | 1922 (16.1) | 237 (23.0) |
| Mild | 3492 (35.8) | 963 (30.8) | 553 (32.4) | 1976 (39.8) | 2780 (36.7) | 231 (33.0) | 481 (32.4) | 3287 (36.6) | 205 (25.0) |
| Moderate | 1612 (16.7) | 498 (15.4) | 279 (16.7) | 835 (17.5) | 1295 (17.3) | 100 (14.2) | 217 (14.6) | 1486 (16.7) | 126 (16.8) |
| Heavy | 2163 (20.6) | 751 (22.4) | 416 (23.4) | 996 (18.7) | 1664 (20.5) | 142 (19.2) | 357 (21.4) | 1929 (20.2) | 234 (25.3) |
| Total-Time physical activity (min/week) | |||||||||
| Inactive | 5309 (46.5) | 1876 (51.3) | 916 (46.6) | 2517 (43.8) | 4025 (45.6) | 432 (51.2) | 852 (49.5) | 4778 (45.7) | 531 (58.0) |
| Active | 5476 (53.5) | 1632 (48.7) | 940 (53.4) | 2904 (56.2) | 4317 (54.4) | 352 (48.8) | 807 (50.5) | 5100 (54.3) | 376 (42.0) |
MedHi: foods containing >104 CFU/g that were categorized as either having Med (104–107 live CFU/g) or Hi (>107 live CFU/g) microbial content.
G1: those without intakes of MedHi foods
G2: those with intakes of MedHi foods (greater than zero but less than the median)
G3: those with intakes of MedHi foods (greater than or equal to the median)
3.2. Association of dietary intake of live microbes with stool types
Participants in the G3 group had a lower risk of hard stools than those in the G1 group (OR = 0.754, 95% CI: 0.613–0.926) after adjusting sex and age, and those in the G3 group were still of lower risks of hard stools (OR = 0.885, 95% CI: 0.692–0.989) after adjusting variables (sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate). In addition, compared with participants in the G1 group, those in the G2 and G3 group showed significant association between dietary intake of live microbes and loose stools (for the G2 group, OR = 0.813, 95% CI: 0.696–0.950; for the G3 group, OR = 0.748, 95% CI: 0.651–0.859) after adjusting sex and age. However, there only existed significant association between dietary intake of live microbes and loose stools in the G3 group (OR = 0.769, 95% CI: 0.585–0.954) after adjusting variables (sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate) (Table 2).
Table 2.
Association between dietary intake of live microbes and stool types in US adult population, NHANES 2005–2010
|
Food category to
stool types |
Model 1 | Model 2 |
|
|
|
|
| OR (95%CI) | OR (95%CI) | |
| Food category to hard stools | ||
| G1 | 1.000 (reference) | 1.000 (reference) |
| G2 | 0.847 (0.655, 1.097) | 0.903 (0.775, 1.130) |
| G3 | 0.754 (0.613, 0.926) | 0.885 (0.692, 0.989) |
| Food category to loose stools | ||
| G1 | 1.000 (reference) | 1.000 (reference) |
| G2 | 0.813 (0.696, 0.950) | 0.843 (0.726, 1.020) |
| G3 | 0.748 (0.651, 0.859) | 0.769 (0.585, 0.954) |
Model 1: adjusted for sex, age.
Model 2: adjusted for sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate.
3.3. Association of dietary intake of live microbes with depression
Compared with participants in the G1 group, those in the G2 and G3 group showed significant association between dietary intake of live microbes and depression (for the G2 group, OR = 0.655, 95% CI: 0.524–0.819; for the G3 group, OR = 0.555, 95% CI: 0.458–0.672) after adjusting sex and age. Moreover, there still existed significant association between dietary intake of live microbes and depression in the G2 group (OR = 0.739, 95% CI: 0.581–0.941) and in the G3 group (OR = 0.716, 95% CI: 0.585–0.877) after adjusting variables (sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate) (Table 3).
Table 3.
Association between dietary intake of live microbes and prevalence of depression in US adult population, NHANES 2005–2010
| Food category | Model 1 | Model 2 |
|
|
|
|
| OR (95%CI) | OR (95%CI) | |
| G1 | 1.000 (reference) | 1.000 (reference) |
| G2 | 0.655 (0.524, 0.819) | 0.739 (0.581, 0.941) |
| G3 | 0.555 (0.458, 0.672) | 0.716 (0.585, 0.877) |
Model 1: adjusted for sex, age.
Model 2: adjusted for sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate.
3.4. Association of stool types with depression
Participants with hard stools and loose stools had high risks of depression than those with normal stools (for hard stools to depression, OR = 1.828, 95% CI: 1.353–2.471; for loose stools to depression, OR = 2.147, 95% CI: 1.649–2.796) after adjusting variables (sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate). Moreover, participants with depression had high risks of hard stools and loose stools than those without depression (for depression to hard stools, OR = 1.825, 95% CI: 1.352–2.462; for depression to loose stools, OR = 2.128, 95% CI: 1.633–2.773) after adjusting for all of the variables (Table 4).
Table 4.
Association between stool types and depression in US adult population, NHANES 2005–2010
| Variables | Model 1 | Model 2 |
|
|
|
|
| OR (95%CI) | OR (95%CI) | |
| stool types to depression | ||
| Normal | 1.000 (reference) | 1.000 (reference) |
| Hard | 1.840 (1.391, 2.435) | 1.828 (1.353, 2.471) |
| Loose | 2.378 (1.826, 3.096) | 2.147 (1.649, 2.796) |
| depression to hard stools | ||
| No | 1.000 (reference) | 1.000 (reference) |
| Yes | 1.853 (1.404, 2.446) | 1.825 (1.352, 2.462) |
| depression to loose stools | ||
| No | 1.000 (reference) | 1.000 (reference) |
| Yes | 2.376 (1.825, 3.093) | 2.128 (1.633, 2.773) |
Model 1: adjusted for sex, age.
Model 2: adjusted for sex, age, race/ethnicity, marital status, smoking, drinking, BMI, physical activity, dietary fibre, and carbohydrate.
3.5. Mediation analyses
We further performed the mediation analyses to evaluate the potential mediation effects of depression on the association between dietary intake of live microbes and stool types, finding that depression had significant mediated effects on the association of dietary intake of live microbes with hard stools and loose stools, and the proportion of mediation was 8.6% and 16.8% respectively (all P < 0.05) (Fig. 1). Similarly, the mediation analyses were also performed to evaluate the potential mediation effects of stool types on the association between dietary intake of live microbes and depression. There were significant mediated effects of hard stools and loose stools on the association between dietary intake of live microbes and depression, and the proportion of mediation was 4.5% and 7.7% respectively (all P < 0.05) (Fig. 2).
Fig. 1.
Estimated mediation effects of depression on the association between dietary live microbes and stool types (A) hard stools (B) loose stools. IE, the estimate of the indirect effect; DE, the estimate of the direct effect; Proportion mediation = IE/(DE + IE)
Fig. 2.
Estimated mediation effects of stool types on the association between dietary live microbes and depression (A) hard stools (B) loose stools. IE, the estimate of the indirect effect; DE, the estimate of the direct effect; Proportion mediation = IE/(DE + IE)
4. Discussion
In this study, we unveiled that there existed lower risks of depression in the G2 and G3 group and lower risks of hard stools and loose stools in the G3 group; moreover, depression and stool types acted as mediators, and vice versa. Furthermore, we documented that dietary intake of live microbes was eligible for simultaneously intervening on depression and stool types.
The phenomenon of comorbidity of depression and gastrointestinal disorders was found [8, 10]. A meta-analysis fleshed out the bidirectional risk of depression and IBD (patients with depression had a 2-fold increased risk of IBD, and IBD patients had a 1.6-fold increased risk of depression) [35]. We further confirmed the bidirectional association between stool types (hard stool and loose stool) and high risk of depression in this study.
We founded that dietary intake of live microbes was required for simultaneously intervening on depression and stool types. Indeed, BGMA, a complex link between the brain and the gut, is responsible for the bidirectional risk of depression and gastrointestinal disorders: the bottom-up signaling of BGMA links gastrointestinal disorders with distorted thinking, maladaptive coping, and mood disturbance; moreover, the top-down signaling of BGMA contributes to the nexus from psychological factors to gastrointestinal disorders. Neural signal networks, immune signal networks, and chemical signal networks render the function of BGMA. Briefly, the vagus nerve [36], Th17/Treg activity [37], microglia [38], inflammatory cytokines [39], short chain fatty acids [40, 41], and gut microbial composition [42] play critical roles in communication between gastrointestinal disorders and depression.
Gut microbiota dysbiosis in patients with MDD is associated with reduced levels of brain-derived neurotrophic factor, and Faecalibacterium is negatively associated with the severity of depressive symptoms [43]. Fecal microbiota transplantation (FMT) ameliorates depressive-like phenotypes of mice and depressive symptom of patients with depression [44, 45]. Bifidobacterium breve CCFM1025 reshapes gut microbiota community, thereby reducing depression-like behavior of mice [46]. Similarly, patients with irritable bowel syndrome (IBS) had high proportions of Bacteroides and Prevotella and high levels of inflammatory markers [47]. Treatment with Bifidobacterium lactis improves symptoms in patients with IBS [48]. Moreover, patients with IBS received FMT reduce the IBS symptoms and the dysbiosis index [49]. Consistent with those above discoveries, we further corroborated that dietary intake of MedHi foods was negatively associated with risk of depression, hard stools, and loose stools. Importantly, we documented the strong relationship between increasing dietary intake of MedHi foods and increasing comorbidity of depression and gastrointestinal disorders. Thus, regulating gut microbiome is feasible for treating gastrointestinal disorders and depression, and a minimum of 66.1 g of MedHi foods per day is recommended.
Our findings demonstrated that the consumption of live microbes may have a dual preventive effect on both mental health and gastrointestinal health, highlighting the importance of dietary interventions in managing and preventing conditions like depression and gastrointestinal disorders. The mutual mediation effects of depression and bowel health in this association underscore the bidirectional relationship between mental and gut health, which is increasingly recognized in the field of preventive medicine [50]. Moreover, our study supports the notion that a diet rich in live microbes can serve as a preventive measure against depression and gastrointestinal disorders. This aligns with the growing body of evidence suggesting that the gut microbiome plays a critical role in modulating immune responses and maintaining overall health [51, 52]. By promoting a diet that includes MedHi foods, we can potentially improve public health outcomes and reduce the burden of these conditions.
Our study has some strengths. First, we explored the association of dietary intake of live microbes with bowel health and depression using large-scale, nationally representative data. Second, we revealed the effect of mediation on linking live microbes with bowel health or depression. There are also limitations in this study. First, recall bias in self-reported data is inherent limitation. Second, it is difficult to infer a causal relationship in this cross-sectional study design. Third, our analysis employed a classification system that did not differentiate between various types of microbes.
5. Conclusion
A high dietary intake of live microbes, especially a minimum of 66.1 g of MedHi foods per day, is associated with a lower risk of depression, hard stools, and loose stools consistency. Depression and bowel health mutually act as mediators in this association, indicating dietary intake of live microbes may simultaneously affect bowel health and depression.
Contributor Information
Jikang Shi, Email: jikangshi@pkuszh.com.
Yi Cheng, Email: chengyi@jlu.edu.cn.
Ming Zhang, Email: mingzhang@pkuszh.com.
Abbreviations
- NHANES
National Health and Nutrition Examination Survey
- OR
odds ratio
- CI
confidence interval
- MDD
major depressive disorder
- IBD
inflammatory bowel disease
- BGMA
brain-gut-microbiome axis
- BSFS
Bristol Stool Form Scale types
- PHQ-9
Patient Health Questionnaire 9
- BMI
Body mass index
Declarations
Ethics approval and consent to participate
The study was approved by the Institutional Review Board (or Ethics Committee) of the institutional review board of the National Center for Health Statistics, CDC. The study protocol is performed in accordance with the principles outlined in the Declaration of Helsinki.
Consent for publication
Not applicable.
Data availability statement
This study used the NHANES publicly available data, https://wwwn.cdc.gov/nchs/nhanes.
Conflicts of interest
The authors declare no conflict of interest.
Funding
Our study was supported by the funds from the Guangdong Basic and Applied Basic Research Foundation (grant number: 2024A1515012768), the Science Technology Department of Suzhou (grant number: SKY2022099), the National Natural Science Foundation of China (grant number: 82373666), and the Department of Science and Technology of Jilin Province (grant number: 20210101464JC).
Author contributions
JS, YC, YL, and MZ designed the study. JS and QZ performed the study and drafted the manuscript. ZL performed the data cleaning. HC analyzed the data. All authors participated in revising the manuscript and approved the final manuscript.
Acknowledgments
We thank all the participants of the study.
References
- 1.O’Connor E H M PL, Coppola EL, Thomas R, Gaynes BN. Screening for Depression, Anxiety, and Suicide Risk in Adults: A Systematic Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No 223 Agency for Healthcare Research and Quality; 2023 AHRQ publication 22-05295-EF-1. [PubMed]
- 2.Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 2007;3:137–58. [DOI] [PubMed] [Google Scholar]
- 3.Gilman SE, Sucha E, Kingsbury M, Horton NJ, Murphy JM, Colman I. Depression and mortality in a longitudinal study: 1952–2011. CMAJ. 2017;189(42):E1304–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gallo JJ, Hwang S, Joo JH, Bogner HR, Morales KH, Bruce ML, Reynolds CF 3rd. Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk. J Gen Intern Med. 2016;31(4):380–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, Kessler RC. The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). Pharmacoeconomics. 2021;39(6):653–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hillilä MT, Hämäläinen J, Heikkinen ME, Färkkilä MA. Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther. 2008;28(5):648–54. [DOI] [PubMed] [Google Scholar]
- 7.Chen D, Zhang Y, Huang T, Jia J. Depression and risk of gastrointestinal disorders: a comprehensive two-sample Mendelian randomization study of European ancestry. Psychol Med. 2023;53(15):7309–21. [DOI] [PubMed] [Google Scholar]
- 8.Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, Iturrino J, Lembo A, Nee J. Chronic Diarrhea and Constipation Are More Common in Depressed Individuals. Clin Gastroenterol Hepatol. 2019;17(13):2696–703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Oliva V, Lippi M, Paci R, Del Fabro L, Delvecchio G, Brambilla P, De Ronchi D, Fanelli G, Serretti A. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110266. [DOI] [PubMed] [Google Scholar]
- 10.Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review. J Psychosom Res. 2016;87:70–80. [DOI] [PubMed] [Google Scholar]
- 11.Cepeda MS, Katz EG, Blacketer C. Microbiome-Gut-Brain Axis: Probiotics and Their Association With Depression. J Neuropsychiatry Clin Neurosci. 2017;29(1):39–44. [DOI] [PubMed] [Google Scholar]
- 12.Collins SM. Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach. Inflamm Bowel Dis. 2020;26(4):493–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One. 2012;7(4):e34938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Yang C, Hong Q, Wu T, Fan Y, Shen X, Dong X. Association between Dietary Intake of Live Microbes and Chronic Constipation in Adults. J Nutr. 2024;154(2):526–34. [DOI] [PubMed] [Google Scholar]
- 15.Han L, Wang Q. Association of Dietary Live Microbe Intake with Cardiovascular Disease in US Adults: A Cross-Sectional Study of NHANES 2007–2018. Nutrients. 2022;14(22). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hill C, Tancredi DJ, Cifelli CJ, Slavin JL, Gahche J, Marco ML, Hutkins R, Fulgoni VL 3rd, Merenstein D, Sanders ME. Positive Health Outcomes Associated with Live Microbe Intake from Foods, Including Fermented Foods, Assessed using the NHANES Database. J Nutr. 2023;153(4):1143–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Huo X, Jia S, Zhang X, Sun L, Liu X, Liu L, Zuo X, Chen X. Association of dietary live microbe intake with abdominal aortic calcification in US adults: a cross-sectional study of NHANES 2013–2014. Front Nutr. 2023;10:1267607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lin J, Yang H, Lin Z, Xu L. Live dietary microbes and reduced prevalence of periodontitis: A cross-sectional study. Oral Dis. 2024. [DOI] [PubMed] [Google Scholar]
- 19.Wang X, Wang H, Yu Q, Fu S, Yang Z, Ye Q, Lin F, Cai G. “High dietary live microbe intake is correlated with reduced risk of depressive symptoms: A cross-sectional study of NHANES 2007–2016”. J Affect Disord. 2024;344:198–206. [DOI] [PubMed] [Google Scholar]
- 20.You Y, Wang R, Li J, Cao F, Zhang Y, Ma X. The Role of Dietary Intake of Live Microbes in the Association Between Leisure-Time Physical Activity and Depressive Symptoms: A Population-based Study. Appl Physiol Nutr Metab. 2024. [DOI] [PubMed] [Google Scholar]
- 21.Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, Memarzadeh MR, Asemi Z, Esmaillzadeh A. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32(3):315–20. [DOI] [PubMed] [Google Scholar]
- 22.Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;2010(11):Cd003048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959–69. [DOI] [PubMed] [Google Scholar]
- 24.Martínez-Martínez MI, Calabuig-Tolsá R, Cauli O. The effect of probiotics as a treatment for constipation in elderly people: A systematic review. Arch Gerontol Geriatr. 2017;71:142–9. [DOI] [PubMed] [Google Scholar]
- 25.Huang R, Hu J. Positive Effect of Probiotics on Constipation in Children: A Systematic Review and Meta-Analysis of Six Randomized Controlled Trials. Front Cell Infect Microbiol. 2017;7:153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.National Health and Nutrition Examination Surveys.
- 27.Marco ML, Hutkins R, Hill C, Fulgoni VL, Cifelli CJ, Gahche J, Slavin JL, Merenstein D, Tancredi DJ, Sanders ME. A Classification System for Defining and Estimating Dietary Intake of Live Microbes in US Adults and Children. J Nutr. 2022;152(7):1729–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–4. [DOI] [PubMed] [Google Scholar]
- 29.Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Jackson SE, Smith L, Firth J, Grabovac I, Soysal P, Koyanagi A, Hu L, Stubbs B, Demurtas J, Veronese N, et al. Is there a relationship between chocolate consumption and symptoms of depression? A cross-sectional survey of 13,626 US adults. Depress Anxiety. 2019;36(10):987–95. [DOI] [PubMed] [Google Scholar]
- 31.Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009;6(6):790–804. [DOI] [PubMed] [Google Scholar]
- 32.Feng Q, Yang Z, May M, Tsoi KK, Ingle S, Lee EK, Wong SY, Kim JH. The role of body mass index in the association between dietary sodium intake and blood pressure: A mediation analysis with NHANES. Nutr Metab Cardiovasc Dis. 2021;31(12):3335–44. [DOI] [PubMed] [Google Scholar]
- 33.Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59. [DOI] [PubMed] [Google Scholar]
- 34.Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2. 2013;(161):1–24. [PubMed] [Google Scholar]
- 35.Bisgaard TH, Allin KH, Elmahdi R, Jess T. The bidirectional risk of inflammatory bowel disease and anxiety or depression: A systematic review and meta-analysis. Gen Hosp Psychiatry. 2023;83:109–16. [DOI] [PubMed] [Google Scholar]
- 36.Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat Rev Endocrinol. 2012;8(12):743–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Poletti S, de Wit H, Mazza E, Wijkhuijs AJM, Locatelli C, Aggio V, Colombo C, Benedetti F, Drexhage HA. Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls. Brain Behav Immun. 2017;61:317–25. [DOI] [PubMed] [Google Scholar]
- 38.Carlessi AS, Borba LA, Zugno AI, Quevedo J, Réus GZ. Gut microbiota-brain axis in depression: The role of neuroinflammation. Eur J Neurosci. 2021;53(1):222–35. [DOI] [PubMed] [Google Scholar]
- 39.Zhang J, Ma L, Chang L, Pu Y, Qu Y, Hashimoto K. A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration. Transl Psychiatry. 2020;10(1):186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461–78. [DOI] [PubMed] [Google Scholar]
- 41.Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Rudzki L, Maes M. The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression. Mol Neurobiol. 2020;57(10):4269–95. [DOI] [PubMed] [Google Scholar]
- 43.Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94. [DOI] [PubMed] [Google Scholar]
- 44.Marcondes Ávila PR, Fiorot M, Michels M, Dominguini D, Abatti M, Vieira A, de Moura AB, Behenck JP, Borba LA, Botelho MEM, et al. Effects of microbiota transplantation and the role of the vagus nerve in gut-brain axis in animals subjected to chronic mild stress. J Affect Disord. 2020;277:410–6. [DOI] [PubMed] [Google Scholar]
- 45.Pu Y, Tan Y, Qu Y, Chang L, Wang S, Wei Y, Wang X, Hashimoto K. A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes. Brain Behav Immun. 2021;94:318–26. [DOI] [PubMed] [Google Scholar]
- 46.Tian P, O’Riordan KJ, Lee YK, Wang G, Zhao J, Zhang H, Cryan JF, Chen W. Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiol Stress. 2020;12:100216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Liu Y, Zhang L, Wang X, Wang Z, Zhang J, Jiang R, Wang X, Wang K, Liu Z, Xia Z, et al. Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression. Clin Gastroenterol Hepatol. 2016;14(11):1602–11.e5. [DOI] [PubMed] [Google Scholar]
- 48.Agrawal A, Houghton LA, Morris J, Reilly B, Guyonnet D, Goupil Feuillerat N, Schlumberger A, Jakob S, Whorwell PJ. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2009;29(1):104–14. [DOI] [PubMed] [Google Scholar]
- 49.El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69(5):859–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Appleton J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integr Med (Encinitas). 2018;17(4):28–32. [PMC free article] [PubMed] [Google Scholar]
- 51.Francis HM, Stevenson RJ, Chambers JR, Gupta D, Newey B, Lim CK. A brief diet intervention can reduce symptoms of depression in young adults - A randomised controlled trial. PLoS One. 2019;14(10):e0222768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jacka FN, O’Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017;15(1):23. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
This study used the NHANES publicly available data, https://wwwn.cdc.gov/nchs/nhanes.